Perubar SA (BVL:PERUBAI1)

Verve Therapeutics Revenue

Perubar had revenue of $6.79M USD in the quarter ending March 31, 2025, a decrease of -2.67%. This brings the company's revenue in the last twelve months to $23.84M, down -11.80% year-over-year. In the year 2024, Perubar had annual revenue of $24.02M, down -9.86%.

• Revenue (ttm): $23.84M
• Revenue Growth: -11.80%
• P/S Ratio: 1.74
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 151.85M

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	24.02M	-2.63M	-9.86%
Dec 31, 2023	26.65M	5.49M	25.96%
Dec 31, 2022	21.16M	-1.29M	-5.73%
Dec 31, 2021	22.44M	3.93M	21.23%
Dec 31, 2020	18.51M	-3.82M	-17.11%